MedTrace Logo

Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI

NCT03301155 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1036

Last updated 2020-05-06

Study results available
· View outcomes & findings →

Summary

The objective of this study is to obtain additional data on the efficacy and safety of 12-week course of therapy with Anaferon for children for prevention of influenza and other acute respiratory viral infections in children during the peaks of seasonal morbidity.

Conditions

  • Preventive Medicine

Interventions

DRUG

Anaferon for children

Tablet for oral use.

DRUG

Placebo

Tablet for oral use.

Sponsors & Collaborators

  • Materia Medica Holding

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-03
Primary Completion
2019-05-20
Completion
2019-05-20

Countries

  • Russia
  • Uzbekistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03301155 on ClinicalTrials.gov